Protease Inhibitor Resistance Analysis in the MONARK Trial...

Antimicrobial Agents and Chemotherapy 2009 / 07 Vol. 53; Iss. 7

Protease Inhibitor Resistance Analysis in the MONARK Trial Comparing First-Line Lopinavir-Ritonavir Monotherapy to Lopinavir-Ritonavir plus Zidovudine and Lamivudine Triple Therapy

Delaugerre, C., Flandre, P., Chaix, M. L., Ghosn, J., Raffi, F., Dellamonica, P., Jaeger, H., Shurmann, D., Cohen-Codar, I., Ngo Van, P., Norton, M., Taburet, A.-M., Delfraissy, J.-F., Rouzioux, C.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
53
Language:
english
Journal:
Antimicrobial Agents and Chemotherapy
DOI:
10.1128/AAC.01643-08
Date:
July, 2009
File:
PDF, 550 KB
english, 2009
Conversion to is in progress
Conversion to is failed